Excellent resource from ABPI_UK to support successful cross-sector collaboration Cancer52 + NRAS, PIF, HRCI, Shared Learning Group on Involvement worked to develop FMV for patient orgs, which is important for partnership working & recognises expertise of charity sector ➡️ bit.ly/3XIG7AB

Cancer52 member charities came together at DHSC with Minister Ashley Dalton MP to help develop the new National Cancer Plan to improve outcomes for those affected by rare & less common cancers Huge thanks to DHSC for hosting & all attendees for their engagement and contributions

Thrilled to attend a workshop on the #NationalCancerPlan at the Department of Health and Social Care offices today. Health Minister, Ashley Dalton, and DHSC officials heard from the #RareAndLessCommonCancer charity community. Huge thanks to Cancer52 also on Bluesky @cancer52org.bsky.social for organising

We're so grateful for the opportunity to take part in this discussion with Ashley Dalton MP and officials, where we came together to talk about how the National Cancer Plan can deliver for young people. We're looking forward to working with the Government to meet this ambition!

We're proud to have met with Ashley Dalton MP and our charity peers yesterday to help shape the new National Cancer Plan 📔 #UntilTheresACure

At our most recent All Member Meeting, we enjoyed a great presentation from Ipsos in the UK outlining their research on gender bias in cancer care. Read more in their report: bit.ly/3Thqlus

Congratulations Jane Lyons MBE!

The team are really excited to be at today’s “The Big Conversation” hosted by Cancer52 also on Bluesky @cancer52org.bsky.social. A packed agenda will include updates on the National Cancer Plan for England, insightful panels, and a session with a member of our Youth Advisory Group.

We’re proud to bring the rare & less common cancer community together at the #BigCancer52Conversation This morning we’ve discussed what’s next in terms of policy for rare and less common cancers with the Rare Cancers Bill and National Cancer Plan

This afternoon at the #BigCancer52Conversation we’re hearing incredible stories of patients' experiences of rare & less common cancers Thank you AstraZeneca UK The National Lottery Community Fund Level39 for making today possible

Thank you to Cancer52 also on Bluesky @cancer52org.bsky.social for an insightful day. Fantastic to see a member of Teenage Cancer Trust ‘s Youth Advisory Group (YAG) sharing her experience so brilliantly and the important role of YAG

A massive thank you to our excellent speakers, panellists, and attendees, who all contributed to the success of our sixth #BigCancer52Conversation yesterday! 👏

On Wednesday, Teenage Cancer Trust attended Cancer52 also on Bluesky @cancer52org.bsky.social “The Big Conversation”. The event brought together charity partners to discuss how to improve patient outcomes for those with rare and less common cancers. (1/5).

Great to hear about partner perspectives on the anticipated National Cancer Plan at Eli Lilly and Company reception today hosted by Clive Jones MP. The Plan is critical to deliver improvements for rare and less common cancers in England.

Cancer52 welcomes the ambitions in the new 10 Year Health Plan, especially on tackling health inequalities & innovation. The focus on prevention, AI, genomics & joined-up care is exciting - hope that the resources will match the ambition. See the Plan: bit.ly/46u5sUC

We are so pleased that the Rare Cancers Bill passed its 3rd Reading in the House of Commons on Friday. This Bill could mark a significant step forward in addressing the urgent need for increased focus and research in the field of rare cancers.

My Rare Cancers Bill cleared the House of Commons on Friday, and had its First Reading in the Lords yesterday. In the Lords, Baroness Elliott of Whitburn Bay will lead on the bill. We are expecting (hoping!) the 2nd Reading will take place in late summer/autumn. Follow its

2.92 million new cancer cases will be rare & less common. We welcome the six tests nominated by #OneCancerVoice. Focussed and targeted action in the new National Cancer Plan is needed to combat the projected increase to and provide a much-needed boost to survival rates.

We welcome the introduction of Jess’s Rule. Our own research found that people often return to their GP several times before being diagnosed with a rare or less common cancer. We hope that the Rule will help avoid late diagnosis and improve outcomes.

Busy time at #Lab25, connecting with policy makers and member charities. With the National Cancer Plan in the final stages of development, it’s a vital time to collaborate to improve outcomes for those affected by rare & less common cancers.